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ABSTRACT
Alternative splicing is an important mechanism for
increasing protein diversity. However, its function-
al effects are largely unknown. Here, we present
our new software workflow composed of the
open-source application AltAnalyze and the
Cytoscape plugin DomainGraph. Both programs
provide an intuitive and comprehensive
end-to-end solution for the analysis and visualiza-
tion of alternative splicing data from Affymetrix
Exon and Gene Arrays at the level of proteins,
domains, microRNA binding sites, molecular inter-
actions and pathways. Our software tools include
easy-to-use graphical user interfaces, rigorous
statistical methods (FIRMA, MiDAS and DABG
filtering) and do not require prior knowledge of
exon array analysis or programming. They
provide new methods for automatic interpretation
and visualization of the effects of alternative exon
inclusion on protein domain composition and
microRNA binding sites. These data can be
visualized together with affected pathways and
gene or protein interaction networks, allowing a
straightforward identification of potential biologic-
al effects due to alternative splicing at different
levels of granularity. Our programs are available
at http://www.altanalyze.org and http://www.
domaingraph.de. These websites also include
extensive documentation, tutorials and sample
data.
INTRODUCTION
Alternative splicing is an important biological mechanism
for producing a great variety of eukaryotic protein
isoforms from a comparatively small number of genes.
Recent studies indicate that 92–94% of all human
multi-exon genes undergo alternative splicing (1). A
large number of alternatively spliced genes and their
protein products are identiﬁed by exon tiling microarrays,
such as the Aﬀymetrix Exon Array (2), as well as by deep
sequencing of transcriptomes (3,4). Important functional
implications of alternative splicing have been
demonstrated for selected genes (5,6), but not yet for the
large majority of splicing events discovered for many
mammalian genes. Splice variants from a single gene
might alter the composition of functional regions, such
as protein domains and other sequence motifs (6) or
prevent protein translation by introducing a premature
stop codon (7). The functional impact of alternative
splicing can be profound, ranging from the gain or loss
of speciﬁc molecular interactions to changes of pathway
dynamics (8). Recently, it was found that alternative
splicing can also regulate the inclusion of microRNA
(miRNA) binding sites as an important means of
controlling protein expression (9). In addition to alterna-
tive splicing, transcription through alternative promoter
selection and alternative 30-end processing by selection
of alternative polyadenylation sites are other critical
modes of transcript regulation that eﬀect protein compos-
ition and expression (10,11).
Several stand-alone programs, web services and
Bioconductor packages have been developed to aid in
the analysis of Aﬀymetrix Exon Array data and to
increase the accuracy and reliability of alternative exon
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tools are principally focused on statistical methods for al-
ternative exon detection, few report the absolute positions
of regulated probesets within transcripts and exons or
relative to other regulated probesets. Furthermore, none
indicate whether these exons have prior evidence of alter-
native splicing or alternative promoter activity and how
such events might alter the protein composition in terms
of putative protein domains, motifs or other important
sequence elements. The programs easyExon (12) and
ExpressionConsole (EC) (http://www.aﬀymetrix.com
/products_services/software/speciﬁc/expression_console
_software.aﬀx) add a few biological annotations to their
expression statistics results such as gene and GO annota-
tions for probesets. However, users have to perform
advanced analyses manually. Other programs, such as
APT (http://www.aﬀymetrix.com/partners_programs/
programs/developer/tools/powertools.aﬀx), MADS (13),
Exonmap (14) and FIRMA (15), concentrate on statistical
computations only. They do not provide an easy-to-use
graphical interface that guides the user through the
analysis, and they require prior knowledge of statistical
programming languages like R (16). Web services, such
as ExonMiner (17), do not depend on additional tools
or prior programming knowledge for the statistical
analysis, but require users to upload their potentially
conﬁdential microarray data. To sum up, few of
these tools provide methods for downstream interpret-
ation of the experimental data, and none of them evalu-
ates the eﬀects of alternative splicing on biological
functions that result from the protein domain compos-
ition, miRNA binding site inclusion and modiﬁed
pathways.
Therefore, we developed an integrated software
workﬂow for the statistical and visual analysis of exon
expression data in the context of interaction networks,
pathways, protein domains and miRNA binding sites.
This workﬂow consists of our programs AltAnalyze and
DomainGraph for exploring the functional impact of al-
ternative splicing and other modes of transcript regulation
in human, mouse and rat. It incorporates the large
majority of analysis options available in other tools (e.g.
DABG ﬁltering, splicing-index, FIRMA and MiDAS) and
provides one of the only end-to-end solutions, from the
statistical analysis of both Exon and Gene Array ﬁles to
probeset-level visualization. Our workﬂow has several
novel features, including the assignment of alternative
splicing annotations and potential miRNA binding sites,
the analysis of protein domains and their interactions, the
visualization of potentially aﬀected biological pathways
and corresponding overrepresentation analysis, and
batch HTML export (see Supplementary Table S1 for a
list of speciﬁc functionalities of AltAnalyze and
DomainGraph and a comprehensive comparison to
other programs).
ANALYSIS WORKFLOW
Our software workﬂow consists of two main components:
AltAnalyze, which performs alternative exon and
functional prediction analyses on Aﬀymetrix Exon Array
ﬁles, and DomainGraph, which is used for the visual in-
vestigation of potential biological eﬀects of alternative
splicing. The results ﬁle produced by AltAnalyze serves
as interface between the two programs (Figure 1). This
ﬁle contains alternative exon scores and P-values for all
examined probesets from the microarray. These probeset
statistics are used as input for DomainGraph, which an-
notates these statistically enriched probesets with gene
and pathway information and allows for investigating
the potential functional implications of regulated
probesets.
AltAnalyze and DomainGraph are both designed to run
on Windows, Unix and Mac OS. AltAnalyze is a stand-
alone, open-source application, while DomainGraph is
designed as a plugin for the free, open-source network
visualization software Cytoscape (18). Both AltAnalyze
and DomainGraph rely on locally installed databases
based on annotation ﬁles provided by Aﬀymetrix and
the corresponding builds of the Ensembl database (19).
New database releases can be downloaded from within
both applications whenever new annotation ﬁles are
made available by Aﬀymetrix. The databases contain all
necessary gene and protein data for the analysis and
visualization of Aﬀymetrix Exon and Gene Array data.
AltAnalyze database ﬁles are stored as tab-delimited text
ﬁles in species- and release-speciﬁc local database
directories. In case of DomainGraph, an embedded
Apache Derby database (http://db.apache.org/derby)
is employed, which maintains all required data
as well as the user’s exon expression data (see
Supplementary Materials and Methods for details on
database contents).
AltAnalyze and DomainGraph can be installed and run
either consecutively or separately on the user’s computer.
The downloadable AltAnalyze package includes both
Cytoscape and DomainGraph, allowing users to run the
complete software workﬂow without a separate installa-
tion of the programs. Users can thus immediately continue
analyzing potential functional implications after the stat-
istical analysis has ﬁnished. For users who prefer to run
AltAnalyze and DomainGraph separately, DomainGraph
is included in the Cytoscape Plugin Manager and can
be downloaded and installed directly from within
Cytoscape.
ALTANALYZE
Users begin the workﬂow by selecting their array type and
species in AltAnalyze along with the option to process raw
Aﬀymetrix CEL ﬁles, already normalized expression ﬁles
in order to identify alternative exon expression between
pairs of biological groups (experimental group versus
control group) or between multiple groups. Analyses can
be performed in either the graphical user interface or by
command-line instructions. Any number of CEL ﬁles for
any number of biological groups and comparisons can be
loaded. The biological groups and comparisons are estab-
lished in the graphical user interface together with expres-
sion and ‘detection above background’ (DABG) P-value
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Once the parameters are speciﬁed, AltAnalyze ﬁrst
performs a ‘robust multi-chip analysis’ (RMA) summar-
ization on the selected CEL ﬁles, retaining only those
probesets that align to a single Ensembl gene. The
output of this step is the gene expression statistics and
annotations for each Ensembl gene and each biological
comparison. Next, the probeset expression values are
ﬁltered based on user-deﬁned absent–present parameters
according to the DABG P-values and absolute expression
levels for each biological comparison, a procedure that is
recommended for alternative exon analysis. These ﬁltered
expression values are used to calculate standard
alternative exon statistics [splicing-index (20), FIRMA
(15), ‘microarray detection of alternative splicing’
(MiDAS) P-value, normalized P-value] for each
analyzed probeset relative to the determined gene expres-
sion levels (see Supplementary Materials and Methods for
further details).
Although AltAnalyze was designed for computing alter-
native exon statistics based on the widely used
splicing-index, FIRMA and MiDAS methods, it is also
able to handle Exon and Gene Array data that was
pre-processed using other statistical algorithms. This
option provides additional ﬂexibility, allowing users to
analyze and interpret potential functional implications of
Figure 1. Software overview. AltAnalyze is shown on the left (A, blue background) and DomainGraph on the right (B, red background). The
alternative exon statistics computed by AltAnalyze form the interface between the two programs and are the starting point for DomainGraph.
The analysis begins with AltAnalyze (START symbol): grouping of raw expression data, normalization, summarization, ﬁltering and calculation
of diﬀerential probeset expression. This results in a series of probeset and gene expression summary ﬁles along with overrepresentation statistics.
The probeset statistics ﬁle can then be loaded into DomainGraph for further investigation. DomainGraph allows for the analysis of a given
experiment (Option 1 symbol) or a given protein or gene interaction network (Option 2 symbol). Option 1 starts with a tabular view of the
data with biological annotations. In Option 2, a given network is augmented with all known protein isoforms, protein domains and domain
interactions.
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their choice.
The output of AltAnalyze is a series of tab-delimited
text ﬁles for each user-deﬁned biological comparison.
These can be opened in spreadsheet programs like
Microsoft Excel or imported directly into DomainGraph
for further analysis and visualization. Besides the alterna-
tive splicing statistics, these tabular data include
domain-level predictions that are complementary to
those found in DomainGraph as well as extended
protein domain and motif predictions using an exhaustive
alternative isoform analysis (21). This latter analysis also
identiﬁes the two most likely competitive isoforms for
each alternative exon (one containing the exon and one
that lacks it). Thus, it can be useful for identifying overall
changes in domain/motif composition and predicted
sequence lengths between these proteins. The predicted
change in protein length and alignment to mRNAs
that do not produce known proteins can be used to
assess the likelihood of nonsense-mediated decay (21).
The AltAnalyze result ﬁles additionally include
overrepresented protein domains/motifs and miRNA
binding sites aﬀected by alternative exon inclusion.
Furthermore, overrepresentation analyses can be per-
formed for pathways annotated by WikiPathways (22)
and Gene Ontology (23), using the integrated program
GO-Elite (24).
DOMAINGRAPH
The latest release 3.0 of the Cytoscape plugin
DomainGraph (25,26) has been designed to directly load
and analyze AltAnalyze alternative exon statistics,
without requiring prior knowledge of genes or pathways
potentially aﬀected by alternative splicing. In addition,
analyses of particular protein and domain interaction
networks and their integration with AltAnalyze statistics
are supported. For this purpose, DomainGraph includes a
mapping between Exon Array probesets and Ensembl
genes, transcripts, exons, proteins and Pfam domains
(27). If a probeset shows signiﬁcant up- or down-
regulation according to the AltAnalyze results, biological
annotations such as gene symbols, WikiPathway and
Reactome (28) pathways, alternative splicing annotations
and miRNA binding sites are automatically displayed.
These biological data can then be easily visualized along
with the eﬀects of alternative splicing on pathways, genes,
transcripts, exons, protein isoforms, protein domains and
miRNA binding sites. Furthermore, users can start the
analysis of AltAnalyze results with any interaction
network or pathway that has been loaded into
DomainGraph. The eﬀects of alternative splicing can be
comprehensively visualized and evaluated at diﬀerent
levels of granularity ranging from network- to exon-level
perspectives.
General analysis of AltAnalyze results
The most direct way to evaluate alternative exon statistics
from AltAnalyze is to view signiﬁcantly up- and
down-regulated probesets in DomainGraph. After
importing the AltAnalyze statistics ﬁle, the user is auto-
matically provided with a ‘Table view’ containing the
AltAnalyze results with information on gene symbols,
Reactome and WikiPathway pathway occurrences,
miRNA binding site disruption and alternative splicing
annotations for each probeset identiﬁed as diﬀerentially
expressed by AltAnalyze (Figure 2, ‘Table view’). Gene
and pathway annotations immediately provide an
overview of the biological context in which the regulation
event occurs. Furthermore, the user can directly get an
idea about the up- and down-regulated probesets
mapping to putative miRNA binding sites and the genes
they belong to. Additionally, several types of alternative
exons are annotated in the table, e.g. exon skipping and
alternative splice sites (see Supplementary Materials and
Methods for all types of alternative exons that can be
detected and the connection between probeset and exon
annotations).
The selection of a gene in the table will display a
‘Network view’ with the gene and all known Ensembl
protein isoforms and their domain compositions
(Figure 2, ‘Network view’). Additionally, a ‘Probeset
view’ shows all these protein isoforms together with con-
stituent Pfam domains, corresponding mRNA transcripts
and exon structures, Aﬀymetrix Exon Array probesets
and miRNA binding sites (Figure 2, ‘Probeset view’). In
this view, probesets are colored according to their diﬀer-
ential expression, pointing users to probesets with a sig-
niﬁcant up- or down-regulation in one of the biological
groups.
The ‘Probeset view’ allows users to directly compare
and analyze alternative exon expression between diﬀerent
protein isoforms produced by one gene. DomainGraph
does not predict new protein isoforms or transcripts, but
uses all information given by Ensembl. This allows users
to view all gene products at once and to determine, which
probesets show up- or down-regulation events and to
which exons (and thus to which transcripts and protein
isoforms) they map. Of course, a single isoform can be
aﬀected by multiple regulation events, which should be
reﬂected by multiple up- or down-regulated probesets
annotated to the respective isoform. As shown in
Figure 3A, observing which alternative exons are present
in which isoforms can lead to the identiﬁcation of the
aﬀected isoforms rather than just a single alternative
exon. By visualizing probesets overlapping with protein
domains or miRNA binding sites, users can visually
assess how an alternative exon may translate into altered
protein function, expression or truncation. Tooltips
provide additional information for the user, including
the splicing-index fold change of probesets,
P-values, alternative splicing annotations and cross-
hybridization types. The latter indicates if a probeset
matches to one or several genomic locations (see
Supplementary Materials and Methods for details on
annotations).
Furthermore, users can select Reactome or
WikiPathways annotations from the table to load and
visualize pathways of interest (Pathway view). These
pathways are automatically overlaid with the AltAnalyze
probeset statistics, and all network nodes associated with
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tate the identiﬁcation of potentially modiﬁed pathways
(Figure 2, ‘Pathway view’). The ‘Table’, ‘Pathway’ and
‘Probeset’ views can be exported as an HTML web
archive, which can be used to publish the data for all
aﬀected genes on a web server.
Overlaying a particular network or pathway with
AltAnalyze results
If a user is interested in a particular interaction network or
pathway, AltAnalyze results can be integrated in order to
evaluate protein isoforms or putative protein domain
interactions and disruptions thereof. To this end, the
user can import either gene or protein interactions into
Cytoscape from a ﬂat ﬁle or by using another Cytoscape
plugin. Interactions can also be obtained from external
pathway resources, such as WikiPathways. If AltAnalyze
data are integrated into DomainGraph, genes, proteins
and domains associated with diﬀerentially expressed
probesets are automatically highlighted (see
Supplementary Materials and Methods).
When importing gene interactions, the focus lies on the
encoded protein isoforms and their domain compositions
to identify those isoforms potentially aﬀected by alterna-
tive splicing and those remaining unchanged. The protein
isoforms and their domains are extracted from the
DomainGraph database (based on Ensembl annotations)
and automatically added to the gene interaction network.
Figure 2. DomainGraph visualization options for AltAnalyze alternative exon statistics. The ‘Table view’ contains all diﬀerentially expressed
probesets with biological annotations. Gene and pathway annotations are clickable and lead to the ‘Pathway’, ‘Network’ and ‘Probeset views’.
The ‘Pathway view’ shows the ‘Focal Adhesion’ WikiPathway; yellow colored gene boxes indicate the presence of alternative exons (see red frame in
‘Table view’). The ‘Probeset view’ displays two protein isoforms (black lines) with constituent domains (red, green and blue rectangles) and mRNA
transcripts (light green, subdivided into exons; identical numbers correspond to the same exons, including 30 and 50 UTRs) produced by FYN.
Probesets are shown below the mRNA transcripts (white boxes are probesets that did not meet the minimum expression thresholds in AltAnalyze;
gray boxes for no alternative expression among the experimental and control groups; green boxes for decreased exon inclusion in the experimental
group; red boxes for increased exon inclusion in experimental group; black frames around gray boxes for alternative splicing annotation). Potential
miRNA binding sites are drawn as blue lines below probesets if present. The ‘Network view’ depicts all known protein isoforms (rectangle nodes)
encoded by FYN together with their constituent domains (diamond nodes). Yellow nodes indicate the node overlaps with regulated probesets. The
protein kinase domain of FYN is highlighted here because their interactions might be altered due to alternative splicing (red circle).
Nucleic AcidsResearch, 2010, Vol.38, WebServer issue W759In contrast, for protein interactions, the focus is on the
underlying domain interactions of speciﬁc protein
isoforms. Domain interactions are automatically derived
from various data sources and interactions potentially
disrupted by alternative splicing according to the
AltAnalyze results can be readily identiﬁed (Figure 3D,
domain interactions obtained from iPfam; 29).
By double-clicking on any gene or protein in the
network, DomainGraph automatically displays the
‘Probeset view’ for that gene.
APPLICATION OF THE ALTANALYZE AND
DOMAINGRAPH WORKFLOW
As an exemplary application of our workﬂow, we chose a
previously described Exon Array dataset (GEO accession
GSE13297) for human embryonic stem cells (hESCs)
diﬀerentiated to cardiac precursors (21). In AltAnalyze,
the Aﬀymetrix CEL ﬁles were processed using default par-
ameters, yielding 4660 alternative probesets for 2477 genes
(Supplementary Data File 1). Over half of these probesets,
2353, aligned to a known alternative splicing event or al-
ternative promoter, and the remainder occurred in either
previously unannotated alternative exons or introns. The
majority of alternatively expressed probesets, 3438 in
total, were predicted to alter the inclusion of protein
domains or protein sequence motifs, while 354 probesets
overlapped with putative miRNA binding sites. A large
subset of alternative probesets, 1647, was predicted to
result in the absence of protein translation due to the
introduction of a premature stop codon or missing
protein annotation. The WikiPathways ‘Focal Adhesion’
(WP306) and ‘mRNA processing’ (WP411) were the most
statistically enriched pathways among all genes with alter-
native exons, based on the GO-Elite results in AltAnalyze
(Supplementary Figure S1).
Importing these results (Supplementary Data File 2)
into DomainGraph displays all alternatively expressed
probesets from AltAnalyze in the ‘Table view’, along
with alternative splicing annotations, aﬀected miRNA
binding sites, associated pathways and gene annotations
(Figure 2). Selection of any gene symbol will build the
‘Network view’ for that gene together with the ‘Probeset
view’, in which the alignment of Exon Array probesets to
exons, transcripts, proteins, domains and miRNA binding
sites is displayed.
For the exemplary dataset, the eﬀect of alternative
probeset expression is diverse in terms of the apparent
mechanism of action and its functional impact. This
includes alternative splicing, alternative promoter selec-
tion, alternative 30-end processing, protein truncation,
protein domain disruption and removal of predicted
miRNA binding sites (Figure 3A–C). While AltAnalyze
provides these predictions for each probeset, only
DomainGraph visualizes the combination of alternative
exon changes and the speciﬁcity of their eﬀect at the tran-
script level. How these alternative exons aﬀect larger bio-
logical processes can be assessed further by examining the
interactions between these alternative genes in biological
pathways or by examining domain interactions between
these genes. For regulated genes associated with the
‘Focal Adhesion’ WikiPathway, the respective interactions
Figure 3. Using the DomainGraph ‘Probeset view’ to determine the mode and eﬀect of alternative exon inclusion. (A) Alternative promoter and
C-terminal exon expression for two protein isoforms of STBN1. Reciprocal expression of two alternative N-terminal exons is shown, along with the
up-regulation of an alternative C-terminal exon, adding several predicted miRNA binding sites and eliminating the presence of a PH domain (green
rectangle). (B) Truncation of EWSR1 by up-regulation of an internal cassette exon. The up-regulation of this exon eliminates several critical protein
domains for this transcription factor. (C) Alternative 30-end processing of Sox21 resulting in a shorter 30UTR and loss of predicted miRNA binding
sites. (D) Impact of alternative exon expression on protein and domain interactions. Five genes of the ‘Focal Adhesion’ WikiPathway are shown.
FYN and FLT1 contain at least one alternative exon overlapping with a protein domain, while SHC1 and SHC3 do not have any regulated probesets
annotated (yellow nodes indicate regulated probesets). Domain interactions (obtained from iPfam) for one protein isoform per gene are shown.
Protein isoforms are depicted as rectangle nodes and constituent domains as diamond nodes. Protein interactions are drawn as blue edges and
domain interactions as green edges.
W760 Nucleic Acids Research, 2010,Vol.38, Web Server issuewere imported into DomainGraph. DomainGraph auto-
matically adds putative domain interactions and
highlights potentially aﬀected domain interactions
(Figure 3D). This interaction network speciﬁcally demon-
strates that alternative exon inclusion within the domain
of both binding partners has the potential to signiﬁcantly
alter the corresponding pathway.
CONCLUSIONS
Our new computational analysis workﬂow provides a con-
venient way of studying the biological impact of alterna-
tive splicing for mammalian genomes at large scale. It is
more amenable even to biologists with limited knowledge
and experience of bioinformatics and programming. The
statistical data processing with AltAnalyze aims at extract-
ing signiﬁcant regulation events from large experimental
datasets in order to support biologists in identifying po-
tentially interesting alternative splicing events. The visual
network analytics provided by DomainGraph can subse-
quently be used to investigate the potential biological im-
plications of such splicing events and related mechanisms
in the context of molecular interactions and binding sites.
In the future, this analysis software may be extended to
incorporate data by other high-throughput exon and
splicing detection methods, for example, deep-sequencing
techniques.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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